Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ticagrelor in Chinese NSTE-ACS patients
NCT02415803Phase 3Unknown
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in non-ST elevation acute coronary syndrome (NSTE-ACS), sponsored by The First Affiliated Hospital of Harbin Medical University. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
non-ST elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT02415803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415803.